Detalles de la búsqueda
1.
Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV - Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial.
EClinicalMedicine
; 60: 102025, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37304494
Resultados
1 -
1
de 1
1
Próxima >
>>